Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Apple Stock Is Ripe for Profit-Taking Now

It has been an amazing run for Apple stock and there should be more to come. But a gift-wrapped performance in AAPL should have investors taking profits in today’s market.

Ambarella Earnings: AMBA Stock Soars 9% on Strong Q3 Results

Ambarella (AMBA) earnings for the semiconductor design company's fiscal third quarter of 2020 have AMBA stock flying high on Monday.

Cannabis Stocks: The Latest Bump Is Only the Beginning

If you are bold enough to act now, there is potential for life-changing profits in cannabis stocks.

Agilent Earnings: A Stock Drops 3% Despite Q4 Beat

Agilent (A) earnings for the research, development and manufacturing company's fiscal fourth quarter of 2019 have A stock down on Monday.

Palo Alto Networks Earnings: PANW Stock Falls 7% on Weak Outlook

Palo Alto (PANW) earnings for the American cybersecurity company's fiscal first quarter of 2020 have PANW stock taking a beating on Monday.

Sorrento Therapeutics News: Why SRNE Stock Is Soaring 89% Today

Sorrento Therapeutics (SRNE) news about the company receiving an unsolicited offer of acquisition has SRNE stock soaring on Monday.

Tiffany & Co. News: TIF Stock Gleams 6% on $16.2 Billion LVMH Deal

Tiffany & Co. (TIF) news about the company agreeing to a $16.20 billion deal with LVMH (LVMUY) has TIF stock taking off on Monday.

The Medicines Company News: MDCO Stock Rockets 22% on Novartis Deal

The Medicines Company (MDCO) news for Monday about a $9.70 billion deal with Novartis (NVS) has MDCO stock heading higher.

Must-Know Levels for Dollar Tree’s Earnings Reaction

Dollar Tree stock is jumping ahead of earnings, causing investors both long and short to take pause ahead of the quarterly print.

Growing Competition Will Impact Qualcomm Stock in the Medium Term

Qualcomm will face increasing competition in the 5G chipset market, which will impact the company's and QCOM stock's growth potential.

The Long-Term Cannabis Story Makes Aurora Stock a Strong Buy

With the MORE Act, higher U.S. approval and presidential candidates commenting, there’s plenty of growth for Aurora stock.

How Much Higher Can Disney+ Push Disney Stock?

Disney stock has been red-hot since the launch of Disney+, but any further near-term gains by DIS stock will likely be limited.

Why You Should Buy PayPal Stock Instead of Square Stock

You should buy PayPal stock instead of Square stock. Square is growing faster but PayPal is more profitable and PYPL stock is cheaper.

Square Stock and the Upside of a “Less Cash” Society

Although Square stock has incurred some volatility, the longer-term outlook for the payment processing specialist is favorable considering society’s push in decreasing cash usage.

It’s Officially Time to Worry About Amazon Stock

The Amazon stock price has faded — and its risks are rising. The issues facing AMZN stock seem more significant than they've been in years.

This Turnaround May Already Be Priced into GE Stock

General Electric's turnaround is still in progress. But the recent rally in the GE stock price may already factor in success. All bets are off whether GE or soar or sink in its turnaround. I'm not willing to take that risk. But investors who believe that GE will not only survive, but thrive as a leaner entity, should consider buying shares today.

Dispatching Travel and Review Sites Is the Next Big Google Stock Catalyst

Alphabet is taking major advertising dollars in the online travel market. But will its moves here put it in the regulatory crosshairs in 2020?

Interested in Chesapeake Energy Stock? Consider CHK’s Bonds First.

Shares of Chesapeake stock have fallen significantly. In cases like CHK, the best course of action is to examine the bonds.

Amarin Stock’s Big Q4 Gains May Not Last as Big Dogs are Barking

Thanks to the effective cardiovascular drug Vascepa, Amarin stock has enjoyed an outsized performance so far this year. However, over the horizon stands big pharmaceutical competitors that are ready to spoil the party.